HostiumCTO Registry
a retrospective, multi-center registry for the evaluation of the clinical outcome following ostial RCA CTO procedures
Log in and participate to the HostiumCTO Registry!
If you’re not a member yet,
please sign up here.
Rationale
Endpoints
Criteria
Procedure protocole
Steering Committee
Rationale
The prevalence of ostial CTO lesion of the RCA is the most prevalent and constitutes an increased challenge during PCI owing to the difficult engagement of the lesion as well as the use of the retrograde approach. The long-term clinical and angiographic outcome of such lesions need to be refined in a large international registry.
Endpoints
Primary Endpoint:
To assess the long-term (>6 months) clinical follow up of patients who underwent a CTO procedure of an ostial RCA.
Secondary Endpoint:
1- Angiographic patency of any stent implanted during the procedure;
Rate of complications (composite of cardiac death, myocardial infarction, major bleeding and cardiac tamponade) of the index procedure .
Criteria
Inclusion critera:
An ostial CTO lesion of the RCA
A > 6 months angiographic follow-up
Exclusion criteria patient-related:
Patient <18 years old
Patient who specifically refused a retrospective assessment of their clinical records
Procedure protocole
Patients will be treated following local standards.
For this registry, the clinical events will be anonymously collected in a secured on-line database indicated for clinical research (https://projectredcap.org/)
Steering Committee
HostiumCTO is governed by a pan-European Steering Committee which is co-chaired by the coordinating investigators (Executive Committee).
Executive Committee
Alexandre Avran
Interventional Cardiologist,
Centre Hospitalier de Valenciennes,
Valenciennes, France
Kambis Mashayekhi
Interventional Cardiologist,
MediClin Heartcenter,
Lahr, Germany
Stéphane Carlier
Interventional Cardiologist,
CHU Ambroise Paré,
Mons, Belgium
Stéphane Rinfret
Interventional Cardiologist,
Emory Heart Center,
Atlanta, United States
Project management
Chadi Ghafari
Mons – Belgium
Study coordination
Egina Timiras
Mons – Belgium
Statistics coordination
Alessandro Scalia
Mons – Belgium
Data Safety Monitoring Board
Roberto Garbo
Interventional Cardiologist,
Maria Pia Hospital,
Torino, Italy
Data Safety Monitoring Board
Thomas Hovasse
Interventional Cardiologist
Hôpital privé Jacques Cartier,
Massy, France